Department of Biology, Faculty of Basic Sciences, Shahed University, Tehran, Iran.
Department of Anatomical Sciences and Pathology, School of Medicine, Shahed University, Tehran, Iran.
Int Immunopharmacol. 2023 Sep;122:110650. doi: 10.1016/j.intimp.2023.110650. Epub 2023 Jul 14.
Acinetobacter baumannii is the leading cause of nosocomial infection. A surface protein commonly known as biofilm associate protein (Bap) has been identified in a bloodstream isolate of A. baumannii. Bap of A. baumannii is involved in intercellular adhesion within the mature biofilm. Outer membrane protein Acinetobacter 87 kDa (Oma87) or β-barrel assembly machinery A (BamA) has been introduced as an immunogenic outer membrane protein via in silico reverse vaccinology. Current research examines the synergistic effect of immunization of mice with both recombinant proteins viz., Oma87 and Bap. Antibodies were raised to the proteins. The mice were challenged with A. baumannii ATCC 19606 and the bacterial burden was enumerated in the mice's livers, spleens, and lungs followed by histological examination. IgG levels significantly increased, and a significant (p < 0.0001) difference was observed between bacterial burdens in the internal organs of the actively and passively immunized groups. Female BALB/c mice weighing 20-25 g, were divided into 4 groups of 14 mice each viz., control, Oma87, Bap, Oma87-Bap groups. The proteins were individually immunogenic, but the combination of both proteins had a synergistic protection property. This is further supported by the histological examination. Based on the results, the combination of Oma87 and Bap may be considered a promising vaccine candidate against A. baumannii .
鲍曼不动杆菌是医院感染的主要原因。在血流分离株中鉴定出一种常见的表面蛋白,称为生物膜相关蛋白(Bap)。鲍曼不动杆菌的 Bap 参与成熟生物膜内的细胞间粘附。外膜蛋白 Acinetobacter 87 kDa(Oma87)或β-桶装配机制 A(BamA)已通过计算机反向疫苗学被引入作为一种免疫原性外膜蛋白。目前的研究检查了用两种重组蛋白(即 Oma87 和 Bap)免疫小鼠的协同效应。针对这些蛋白产生了抗体。用 A.baumannii ATCC 19606 对小鼠进行了攻毒,然后对小鼠肝脏、脾脏和肺部中的细菌负荷进行了计数,并进行了组织学检查。IgG 水平显著升高,主动免疫和被动免疫组的内脏器官中的细菌负荷之间存在显著差异(p<0.0001)。将 20-25g 的雌性 BALB/c 小鼠分为 4 组,每组 14 只,分别为对照组、Oma87 组、Bap 组、Oma87-Bap 组。这些蛋白均具有免疫原性,但两者的组合具有协同保护作用。组织学检查进一步支持了这一点。基于这些结果,Oma87 和 Bap 的组合可能被认为是一种有前途的针对鲍曼不动杆菌的候选疫苗。